Dicerna Pharmaceuticals' Partnership

Dicerna Pharmaceuticals raised a round of funding on January 11, 2010. Investors include Kyowa Hakko Kirin Co..

Dicerna Pharmaceuticals is a pharmaceutical company developing RNA interference (RNAi)-based therapeutics against genetically-defined targets in multiple disease areas, including cancer. Dicerna's the…

Articles about Dicerna Pharmaceuticals' Partnership: